Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
A Case of Daptomycin-Induced Acute Cholestatic Hepatic Injury With Fatal Outcomes.

American journal of therapeutics

Gkoufa A, Goutas D, Sakellariou S, Cholongitas E.
PMID: 33852481
Am J Ther. 2021 Apr 07; doi: 10.1097/MJT.0000000000001310. Epub 2021 Apr 07.

No abstract available.

Cite
Gkoufa A, Goutas D, Sakellariou S, et al. A Case of Daptomycin-Induced Acute Cholestatic Hepatic Injury With Fatal Outcomes. Am J Ther. 2021;doi: 10.1097/MJT.0000000000001310.
Gkoufa, A., Goutas, D., Sakellariou, S., & Cholongitas, E. (2021). A Case of Daptomycin-Induced Acute Cholestatic Hepatic Injury With Fatal Outcomes. American journal of therapeutics, . https://doi.org/10.1097/MJT.0000000000001310
Gkoufa, Aikaterini, et al. "A Case of Daptomycin-Induced Acute Cholestatic Hepatic Injury With Fatal Outcomes." American journal of therapeutics vol. (2021). doi: https://doi.org/10.1097/MJT.0000000000001310
Gkoufa A, Goutas D, Sakellariou S, Cholongitas E. A Case of Daptomycin-Induced Acute Cholestatic Hepatic Injury With Fatal Outcomes. Am J Ther. 2021 Apr 07; doi: 10.1097/MJT.0000000000001310. Epub 2021 Apr 07. PMID: 33852481.
Copy Download .nbib Format: NLM
Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia.

Diagnostics (Basel, Switzerland)

Goutas D, Theocharis S, Tsourouflis G.
PMID: 34441281
Diagnostics (Basel). 2021 Jul 26;11(8). doi: 10.3390/diagnostics11081346.

Histone deacetylases (HDACs) have long been implicated in tumorigenesis and tumor progression demonstrating their important participation in neoplasia. Therefore, numerous studies have been performed, highlighting the mechanism of HDACs action in tumor cells and demonstrating the potential role of...

Cite
Goutas D, Theocharis S, Tsourouflis G. Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia. Diagnostics (Basel). 2021;11(8)doi: 10.3390/diagnostics11081346.
Goutas, D., Theocharis, S., & Tsourouflis, G. (2021). Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia. Diagnostics (Basel, Switzerland), 11(8), . https://doi.org/10.3390/diagnostics11081346
Goutas, Dimitrios, et al. "Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia." Diagnostics (Basel, Switzerland) vol. 11,8 (2021). doi: https://doi.org/10.3390/diagnostics11081346
Goutas D, Theocharis S, Tsourouflis G. Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia. Diagnostics (Basel). 2021 Jul 26;11(8). doi: 10.3390/diagnostics11081346. PMID: 34441281; PMCID: PMC8394077.
Copy Download .nbib Format: NLM
HuR as Therapeutic Target in Cancer: What the Future Holds.

Current medicinal chemistry

Goutas D, Pergaris A, Giaginis C, Theocharis S.
PMID: 34182901
Curr Med Chem. 2021 Jun 28; doi: 10.2174/0929867328666210628143430. Epub 2021 Jun 28.

ELAV-like protein 1, or HuR (human antigen R), is an RNA-binding protein encoded by the ELAVL1 gene in humans. One of its best functions is to stabilize mRNAs in order to regulate gene expression. HuR protein overexpression has undoubtedly...

Cite
Goutas D, Pergaris A, Giaginis C, et al. HuR as Therapeutic Target in Cancer: What the Future Holds. Curr Med Chem. 2021;doi: 10.2174/0929867328666210628143430.
Goutas, D., Pergaris, A., Giaginis, C., & Theocharis, S. (2021). HuR as Therapeutic Target in Cancer: What the Future Holds. Current medicinal chemistry, . https://doi.org/10.2174/0929867328666210628143430
Goutas, Dimitrios, et al. "HuR as Therapeutic Target in Cancer: What the Future Holds." Current medicinal chemistry vol. (2021). doi: https://doi.org/10.2174/0929867328666210628143430
Goutas D, Pergaris A, Giaginis C, Theocharis S. HuR as Therapeutic Target in Cancer: What the Future Holds. Curr Med Chem. 2021 Jun 28; doi: 10.2174/0929867328666210628143430. Epub 2021 Jun 28. PMID: 34182901.
Copy Download .nbib Format: NLM
Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling.

Neuro-Chirurgie

Nikova AS, Sioutas GS, Sfyrlida K, Tripsianis G, Karanikas M, Birbilis T.
PMID: 33845117
Neurochirurgie. 2021 Apr 15; doi: 10.1016/j.neuchi.2021.03.012. Epub 2021 Apr 15.

OBJECTIVE: Posterior communicating artery aneurysms (PCoAA) usually present with brain hemorrhage, but they might present with oculomotor nerve palsy (ONP) in about one out of five patients. Treatment options include endovascular coiling and surgical clipping. The present analysis aims...

Cite
Nikova AS, Sioutas GS, Sfyrlida K, et al. Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neurochirurgie. 2021;doi: 10.1016/j.neuchi.2021.03.012.
Nikova, A. S., Sioutas, G. S., Sfyrlida, K., Tripsianis, G., Karanikas, M., & Birbilis, T. (2021). Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neuro-Chirurgie, . https://doi.org/10.1016/j.neuchi.2021.03.012
Nikova, A S, et al. "Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling." Neuro-Chirurgie vol. (2021). doi: https://doi.org/10.1016/j.neuchi.2021.03.012
Nikova AS, Sioutas GS, Sfyrlida K, Tripsianis G, Karanikas M, Birbilis T. Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neurochirurgie. 2021 Apr 15; doi: 10.1016/j.neuchi.2021.03.012. Epub 2021 Apr 15. PMID: 33845117.
Copy Download .nbib Format: NLM
HuR as Therapeutic Target in Cancer: What the Future Holds.

Current medicinal chemistry

Goutas D, Pergaris A, Giaginis C, Theocharis S.
PMID: 34182901
Curr Med Chem. 2022;29(1):56-65. doi: 10.2174/0929867328666210628143430.

ELAV-like protein 1 or HuR (human antigen R) is an RNA-binding protein that in humans is encoded by the ELAVL1 gene, and one of its best functions is to stabilize mRNAs in order to regulate gene expression. HuR protein...

Cite
Goutas D, Pergaris A, Giaginis C, et al. HuR as Therapeutic Target in Cancer: What the Future Holds. Curr Med Chem. 2022;29(1):56-65doi: 10.2174/0929867328666210628143430.
Goutas, D., Pergaris, A., Giaginis, C., & Theocharis, S. (2022). HuR as Therapeutic Target in Cancer: What the Future Holds. Current medicinal chemistry, 29(1), 56-65. https://doi.org/10.2174/0929867328666210628143430
Goutas, Dimitrios, et al. "HuR as Therapeutic Target in Cancer: What the Future Holds." Current medicinal chemistry vol. 29,1 (2022): 56-65. doi: https://doi.org/10.2174/0929867328666210628143430
Goutas D, Pergaris A, Giaginis C, Theocharis S. HuR as Therapeutic Target in Cancer: What the Future Holds. Curr Med Chem. 2022;29(1):56-65. doi: 10.2174/0929867328666210628143430. PMID: 34182901.
Copy Download .nbib Format: NLM
Robot-assisted carotid artery stenting: outcomes, safety, and operational learning curve.

Neurosurgical focus

Abbas R, Al Saiegh F, El Naamani K, Chen CJ, Velagapudi L, Sioutas GS, Weinberg JH, Tjoumakaris S, Gooch MR, Herial NA, Rosenwasser RH, Jabbour P.
PMID: 34973670
Neurosurg Focus. 2022 Jan;52(1):E17. doi: 10.3171/2021.10.FOCUS21504.

OBJECTIVE: Over the past 2 decades, robots have been increasingly used in surgeries to help overcome human limitations and perform precise and accurate tasks. Endovascular robots were pioneered in interventional cardiology, however, the CorPath GRX was recently approved by...

Cite
Abbas R, Al Saiegh F, El Naamani K, et al. Robot-assisted carotid artery stenting: outcomes, safety, and operational learning curve. Neurosurg Focus. 2022;52(1):E17doi: 10.3171/2021.10.FOCUS21504.
Abbas, R., Al Saiegh, F., El Naamani, K., Chen, C. J., Velagapudi, L., Sioutas, G. S., Weinberg, J. H., Tjoumakaris, S., Gooch, M. R., Herial, N. A., Rosenwasser, R. H., & Jabbour, P. (2022). Robot-assisted carotid artery stenting: outcomes, safety, and operational learning curve. Neurosurgical focus, 52(1), E17. https://doi.org/10.3171/2021.10.FOCUS21504
Abbas, Rawad, et al. "Robot-assisted carotid artery stenting: outcomes, safety, and operational learning curve." Neurosurgical focus vol. 52,1 (2022): E17. doi: https://doi.org/10.3171/2021.10.FOCUS21504
Abbas R, Al Saiegh F, El Naamani K, Chen CJ, Velagapudi L, Sioutas GS, Weinberg JH, Tjoumakaris S, Gooch MR, Herial NA, Rosenwasser RH, Jabbour P. Robot-assisted carotid artery stenting: outcomes, safety, and operational learning curve. Neurosurg Focus. 2022 Jan;52(1):E17. doi: 10.3171/2021.10.FOCUS21504. PMID: 34973670.
Copy Download .nbib Format: NLM
Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.

Cytopathology : official journal of the British Society for Clinical Cytology

Goutas D, Savvidou K, Vrettou K, Meletis E, Levis P, Constantinides C, Lazaris AC, Mikou P.
PMID: 34289188
Cytopathology. 2021 Nov;32(6):795-801. doi: 10.1111/cyt.13040. Epub 2021 Aug 04.

BACKGROUND: This retrospective study was conducted to compare the conventional cytospin method and ThinPrep liquid-based urinary cytology in diagnosing bladder cancer using The Paris System (TPS) of classification.METHODS: We retrieved files for 2020, at the Cytopathology Department of Laiko...

Cite
Goutas D, Savvidou K, Vrettou K, et al. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology. Cytopathology. 2021;32(6):795-801doi: 10.1111/cyt.13040.
Goutas, D., Savvidou, K., Vrettou, K., Meletis, E., Levis, P., Constantinides, C., Lazaris, A. C., & Mikou, P. (2021). Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology. Cytopathology : official journal of the British Society for Clinical Cytology, 32(6), 795-801. https://doi.org/10.1111/cyt.13040
Goutas, Dimitris, et al. "Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology." Cytopathology : official journal of the British Society for Clinical Cytology vol. 32,6 (2021): 795-801. doi: https://doi.org/10.1111/cyt.13040
Goutas D, Savvidou K, Vrettou K, Meletis E, Levis P, Constantinides C, Lazaris AC, Mikou P. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology. Cytopathology. 2021 Nov;32(6):795-801. doi: 10.1111/cyt.13040. Epub 2021 Aug 04. PMID: 34289188.
Copy Download .nbib Format: NLM
Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling.

Neuro-Chirurgie

Nikova AS, Sioutas GS, Sfyrlida K, Tripsianis G, Karanikas M, Birbilis T.
PMID: 33845117
Neurochirurgie. 2022 Jan;68(1):86-93. doi: 10.1016/j.neuchi.2021.03.012. Epub 2021 Apr 15.

OBJECTIVE: Posterior communicating artery aneurysms (PCoAA) usually present with brain hemorrhage, but they might present with oculomotor nerve palsy (ONP) in about one out of five patients. Treatment options include endovascular coiling and surgical clipping. The present analysis aims...

Cite
Nikova AS, Sioutas GS, Sfyrlida K, et al. Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neurochirurgie. 2021;68(1):86-93doi: 10.1016/j.neuchi.2021.03.012.
Nikova, A. S., Sioutas, G. S., Sfyrlida, K., Tripsianis, G., Karanikas, M., & Birbilis, T. (2022). Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neuro-Chirurgie, 68(1), 86-93. https://doi.org/10.1016/j.neuchi.2021.03.012
Nikova, A S, et al. "Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling." Neuro-Chirurgie vol. 68,1 (2022): 86-93. doi: https://doi.org/10.1016/j.neuchi.2021.03.012
Nikova AS, Sioutas GS, Sfyrlida K, Tripsianis G, Karanikas M, Birbilis T. Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neurochirurgie. 2022 Jan;68(1):86-93. doi: 10.1016/j.neuchi.2021.03.012. Epub 2021 Apr 15. PMID: 33845117.
Copy Download .nbib Format: NLM
SARS-CoV-2 Molecular Transmission Clusters and Containment Measures in Ten European Regions during the First Pandemic Wave.

Life (Basel, Switzerland)

Bousali M, Dimadi A, Kostaki EG, Tsiodras S, Nikolopoulos GK, Sgouras DN, Magiorkinis G, Papatheodoridis G, Pogka V, Lourida G, Argyraki A, Angelakis E, Sourvinos G, Beloukas A, Paraskevis D, Karamitros T.
PMID: 33803490
Life (Basel). 2021 Mar 09;11(3). doi: 10.3390/life11030219.

BACKGROUND: The spatiotemporal profiling of molecular transmission clusters (MTCs) using viral genomic data can effectively identify transmission networks in order to inform public health actions targeting SARS-CoV-2 spread.METHODS: We used whole genome SARS-CoV-2 sequences derived from ten European regions...

Cite
Bousali M, Dimadi A, Kostaki EG, et al. SARS-CoV-2 Molecular Transmission Clusters and Containment Measures in Ten European Regions during the First Pandemic Wave. Life (Basel). 2021;11(3)doi: 10.3390/life11030219.
Bousali, M., Dimadi, A., Kostaki, E. G., Tsiodras, S., Nikolopoulos, G. K., Sgouras, D. N., Magiorkinis, G., Papatheodoridis, G., Pogka, V., Lourida, G., Argyraki, A., Angelakis, E., Sourvinos, G., Beloukas, A., Paraskevis, D., & Karamitros, T. (2021). SARS-CoV-2 Molecular Transmission Clusters and Containment Measures in Ten European Regions during the First Pandemic Wave. Life (Basel, Switzerland), 11(3), . https://doi.org/10.3390/life11030219
Bousali, Maria, et al. "SARS-CoV-2 Molecular Transmission Clusters and Containment Measures in Ten European Regions during the First Pandemic Wave." Life (Basel, Switzerland) vol. 11,3 (2021). doi: https://doi.org/10.3390/life11030219
Bousali M, Dimadi A, Kostaki EG, Tsiodras S, Nikolopoulos GK, Sgouras DN, Magiorkinis G, Papatheodoridis G, Pogka V, Lourida G, Argyraki A, Angelakis E, Sourvinos G, Beloukas A, Paraskevis D, Karamitros T. SARS-CoV-2 Molecular Transmission Clusters and Containment Measures in Ten European Regions during the First Pandemic Wave. Life (Basel). 2021 Mar 09;11(3). doi: 10.3390/life11030219. PMID: 33803490; PMCID: PMC8001481.
Copy Download .nbib Format: NLM
Impact of .

Microorganisms

Kontizas E, Tastsoglou S, Karamitros T, Karayiannis Y, Kollia P, Hatzigeorgiou AG, Sgouras DN.
PMID: 33339161
Microorganisms. 2020 Dec 16;8(12). doi: 10.3390/microorganisms8122007.

No abstract available.

Cite
Kontizas E, Tastsoglou S, Karamitros T, et al. Impact of . Microorganisms. 2020;8(12)doi: 10.3390/microorganisms8122007.
Kontizas, E., Tastsoglou, S., Karamitros, T., Karayiannis, Y., Kollia, P., Hatzigeorgiou, A. G., & Sgouras, D. N. (2020). Impact of . Microorganisms, 8(12), . https://doi.org/10.3390/microorganisms8122007
Kontizas, Eleftherios, et al. "Impact of ." Microorganisms vol. 8,12 (2020). doi: https://doi.org/10.3390/microorganisms8122007
Kontizas E, Tastsoglou S, Karamitros T, Karayiannis Y, Kollia P, Hatzigeorgiou AG, Sgouras DN. Impact of . Microorganisms. 2020 Dec 16;8(12). doi: 10.3390/microorganisms8122007. PMID: 33339161; PMCID: PMC7765595.
Copy Download .nbib Format: NLM
SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation.

Clinical case reports

Milionis V, Goutas D, Vlachodimitropoulos D, Katsoulas N, Kyriazis ID, Liatsikos EN, Marinakis N, Joanne TS, Lazaris AC, Goutas N.
PMID: 34703596
Clin Case Rep. 2021 Oct 18;9(10):e04605. doi: 10.1002/ccr3.4605. eCollection 2021 Oct.

The highly syndromic nature of succinate dehydrogenase-deficient RCCs constitutes their active surveillance and molecular profiling the alpha and omega.

Cite
Milionis V, Goutas D, Vlachodimitropoulos D, et al. SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation. Clin Case Rep. 2021;9(10):e04605doi: 10.1002/ccr3.4605.
Milionis, V., Goutas, D., Vlachodimitropoulos, D., Katsoulas, N., Kyriazis, I. D., Liatsikos, E. N., Marinakis, N., Joanne, T. S., Lazaris, A. C., & Goutas, N. (2021). SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation. Clinical case reports, 9(10), e04605. https://doi.org/10.1002/ccr3.4605
Milionis, Vassilis, et al. "SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation." Clinical case reports vol. 9,10 (2021): e04605. doi: https://doi.org/10.1002/ccr3.4605
Milionis V, Goutas D, Vlachodimitropoulos D, Katsoulas N, Kyriazis ID, Liatsikos EN, Marinakis N, Joanne TS, Lazaris AC, Goutas N. SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation. Clin Case Rep. 2021 Oct 18;9(10):e04605. doi: 10.1002/ccr3.4605. eCollection 2021 Oct. PMID: 34703596; PMCID: PMC8522490.
Copy Download .nbib Format: NLM
Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance.

Cancers

Goutas D, Goutas N, Theocharis S.
PMID: 34572861
Cancers (Basel). 2021 Sep 15;13(18). doi: 10.3390/cancers13184634.

Pancreatic cancer is set to become the most lethal and common type of cancer worldwide. This is partly attributed to the mutational burden that affects core signaling pathways and the crosstalk of tumor cells with their surrounding microenvironment, but...

Cite
Goutas D, Goutas N, Theocharis S. Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance. Cancers (Basel). 2021;13(18)doi: 10.3390/cancers13184634.
Goutas, D., Goutas, N., & Theocharis, S. (2021). Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance. Cancers, 13(18), . https://doi.org/10.3390/cancers13184634
Goutas, Dimitrios, et al. "Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance." Cancers vol. 13,18 (2021). doi: https://doi.org/10.3390/cancers13184634
Goutas D, Goutas N, Theocharis S. Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance. Cancers (Basel). 2021 Sep 15;13(18). doi: 10.3390/cancers13184634. PMID: 34572861; PMCID: PMC8471481.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries